| Ms Nancy Lynn Baron, CNM | |
|
3440 Burnet Ave, Ste. 120, Cincinnati, OH 45229-2833 | |
| (513) 751-5900 | |
| (513) 487-4590 |
| Full Name | Ms Nancy Lynn Baron |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 36 Years |
| Location | 3440 Burnet Ave, Cincinnati, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134129752 | NPI | - | NPPES |
| 200409820A | Medicaid | IN | |
| 78008653 | Medicaid | KY | |
| 0749195 | Medicaid | OH | |
| 200409820B | Medicaid | IN | |
| 200409820C | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | NM00394 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Trihealth H Llc | 1850570458 | 668 |
News Archive
Scientists have discovered a new genetic disease, which causes some children's brains to develop abnormally, resulting in delayed intellectual development and often early onset cataracts.
The results of two studies in the August 15 issue of JAMA report on the psychological status of workers at the Fukushima nuclear power plants in Japan several months after the earthquake and tsunami in March 2011, and the amount of internal radiation exposure among residents of a city north of the power plant that experienced a meltdown.
Novartis announced today that Tasigna (nilotinib) 200 mg capsules met its primary endpoint in the first head-to-head comparison with the company's groundbreaking drug Gleevec (imatinib mesylate) tablets*. Tasigna produced faster and deeper responses than Gleevec when given as first-line therapy for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna was well tolerated in the study.
Van Andel Institute announces that researchers at Lund University in Sweden have published a study detailing how Parkinson's disease spreads through the brain. Experiments in rat models uncover a process previously used to explain mad cow disease, in which misfolded proteins travel from sick to healthy cells.
The most effective, life-saving treatment for a severe allergic reaction is epinephrine. Yet a new study shows in an emergency, 52 percent of adults with potentially life-threatening allergies didn't use the epinephrine auto-injectors they were prescribed.
› Verified 7 days ago
| Entity Name | Trihealth G Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295862944 PECOS PAC ID: 0749222651 Enrollment ID: O20050601000358 |
News Archive
Scientists have discovered a new genetic disease, which causes some children's brains to develop abnormally, resulting in delayed intellectual development and often early onset cataracts.
The results of two studies in the August 15 issue of JAMA report on the psychological status of workers at the Fukushima nuclear power plants in Japan several months after the earthquake and tsunami in March 2011, and the amount of internal radiation exposure among residents of a city north of the power plant that experienced a meltdown.
Novartis announced today that Tasigna (nilotinib) 200 mg capsules met its primary endpoint in the first head-to-head comparison with the company's groundbreaking drug Gleevec (imatinib mesylate) tablets*. Tasigna produced faster and deeper responses than Gleevec when given as first-line therapy for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna was well tolerated in the study.
Van Andel Institute announces that researchers at Lund University in Sweden have published a study detailing how Parkinson's disease spreads through the brain. Experiments in rat models uncover a process previously used to explain mad cow disease, in which misfolded proteins travel from sick to healthy cells.
The most effective, life-saving treatment for a severe allergic reaction is epinephrine. Yet a new study shows in an emergency, 52 percent of adults with potentially life-threatening allergies didn't use the epinephrine auto-injectors they were prescribed.
› Verified 7 days ago
| Entity Name | Trihealth H Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811215742 PECOS PAC ID: 1850570458 Enrollment ID: O20110128000356 |
News Archive
Scientists have discovered a new genetic disease, which causes some children's brains to develop abnormally, resulting in delayed intellectual development and often early onset cataracts.
The results of two studies in the August 15 issue of JAMA report on the psychological status of workers at the Fukushima nuclear power plants in Japan several months after the earthquake and tsunami in March 2011, and the amount of internal radiation exposure among residents of a city north of the power plant that experienced a meltdown.
Novartis announced today that Tasigna (nilotinib) 200 mg capsules met its primary endpoint in the first head-to-head comparison with the company's groundbreaking drug Gleevec (imatinib mesylate) tablets*. Tasigna produced faster and deeper responses than Gleevec when given as first-line therapy for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna was well tolerated in the study.
Van Andel Institute announces that researchers at Lund University in Sweden have published a study detailing how Parkinson's disease spreads through the brain. Experiments in rat models uncover a process previously used to explain mad cow disease, in which misfolded proteins travel from sick to healthy cells.
The most effective, life-saving treatment for a severe allergic reaction is epinephrine. Yet a new study shows in an emergency, 52 percent of adults with potentially life-threatening allergies didn't use the epinephrine auto-injectors they were prescribed.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Nancy Lynn Baron, CNM 4685 Forest Ave, Ste C, Cincinnati, OH 45212-3359 Ph: (513) 569-5027 | Ms Nancy Lynn Baron, CNM 3440 Burnet Ave, Ste. 120, Cincinnati, OH 45229-2833 Ph: (513) 751-5900 |
News Archive
Scientists have discovered a new genetic disease, which causes some children's brains to develop abnormally, resulting in delayed intellectual development and often early onset cataracts.
The results of two studies in the August 15 issue of JAMA report on the psychological status of workers at the Fukushima nuclear power plants in Japan several months after the earthquake and tsunami in March 2011, and the amount of internal radiation exposure among residents of a city north of the power plant that experienced a meltdown.
Novartis announced today that Tasigna (nilotinib) 200 mg capsules met its primary endpoint in the first head-to-head comparison with the company's groundbreaking drug Gleevec (imatinib mesylate) tablets*. Tasigna produced faster and deeper responses than Gleevec when given as first-line therapy for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna was well tolerated in the study.
Van Andel Institute announces that researchers at Lund University in Sweden have published a study detailing how Parkinson's disease spreads through the brain. Experiments in rat models uncover a process previously used to explain mad cow disease, in which misfolded proteins travel from sick to healthy cells.
The most effective, life-saving treatment for a severe allergic reaction is epinephrine. Yet a new study shows in an emergency, 52 percent of adults with potentially life-threatening allergies didn't use the epinephrine auto-injectors they were prescribed.
› Verified 7 days ago
Mrs. Meryll Guillory Thomas-langford, APRN.CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3219 Clifton Ave Ste 210, Cincinnati, OH 45220 Phone: 513-751-5900 | |
Leah A. Terhune, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 4244 Hamilton Ave, Cincinnati, OH 45223 Phone: 513-681-4900 Fax: 513-853-8432 | |
Donna O Patno, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3333 Burnet Ave, Cincinnati, OH 45229 Phone: 513-636-9608 | |
Deena Jo Parsons, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 3440 Burnet Ave, Suite 120, Cincinnati, OH 45229 Phone: 513-751-5900 Fax: 513-487-4590 | |
Mrs. Andrea Chipps, CNM, APRN Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3440 Burnet Ave, Cincinnati, OH 45229 Phone: 513-751-5900 | |
Sapphira Champange Pranger, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3219 Clifton Ave Ste 210, Cincinnati, OH 45220 Phone: 513-751-5900 Fax: 513-487-4590 |